Accept Refuse

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 62016CN0497

Case C-497/16: Request for a preliminary ruling from the Nejvyšší soud České republiky (Czech Republic) lodged on 16 September 2016 — Criminal proceedings against Juraj Sokáč

OJ C 22, 23.1.2017, p. 2–2 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

23.1.2017   

EN

Official Journal of the European Union

C 22/2


Request for a preliminary ruling from the Nejvyšší soud České republiky (Czech Republic) lodged on 16 September 2016 — Criminal proceedings against Juraj Sokáč

(Case C-497/16)

(2017/C 022/02)

Language of the case: Czech

Referring court

Nejvyšší soud České republiky

Party to the main proceedings

Juraj Sokáč

Question referred

Can medicinal products as defined in Directive 2001/83/EC (1) of the European Parliament and of the Council, which contain ‘scheduled substances’ as laid down by Regulation (EU) No 273/2004 (2) of the European Parliament and of the Council, be regarded as excluded, on the basis of Article 2(a) of that regulation, from the scope of the Regulation in accordance with the judgment of the Court of Justice of the European Union in Joined Cases C-627/13 and C-2/14, even after amendment of that provision by Regulation No 1258/2013 (3) and in view of the fact that Article 2(a) of Regulation No 111/2005 (4) as amended by Regulation No 1259/2013 (5) brings medicinal products containing ephedrine and pseudoephedrine within the system laid down by Regulation No 111/2005?


(1)  OJ 2001 L 311, p. 67.

(2)  OJ 2004 L 47, p. 1.

(3)  OJ 2013 L 330, p. 21.

(4)  OJ 2005 L 22, p. 1.

(5)  OJ 2013 L 330, p. 30.


Top